Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex for Capillary Plexus Density in DME
NCT04038125Phase 4Unknown
- Sponsor
- Retina Macula Specialists of Miami
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Retina Macula Specialists of Miami. Status: unknown.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04038125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04038125.